Quantum-Si to Participate in Upcoming Investment Conferences

QSI 11.05.2024

Full Press ReleaseSEC FilingsOur QSI Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Microproteins and the Dark Proteome: Tiny Molecules with Big Potential
  • 01.22.2025 - Quantum-Si’s Innovative Protein Barcoding Enhances Next-Gen Screening for mRNA Therapeutics
  • 01.20.2025 - Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK

Recent Filings

    BRANFORD, Conn.--(BUSINESS WIRE)--Nov. 5, 2024--Quantum-Si Incorporated(Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in two upcoming investment conferences.

    Jeff Hawkins,Quantum-Si'sChief Executive Officer, will participate in a fireside chat discussion at theUBS Global Healthcare ConferenceonWednesday, November 13th, at8:45 AM PT.

    OnThursday, November 21stat8:00 AM ET,Mr. Hawkinswill participate in a fireside chat discussion at the Canaccord Medtech,Diagnostics & Services ForuminNew York City.

    A live and archived webcast of the event will be available in the “Investors” section of theQuantum-Siwebsite underEvents & Presentations.

    AboutQuantum-Si Incorporated

    Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein SequencingTM that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more atquantum-si.comor follow us onLinkedInorX.

    View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241105331252/en/

    Investor ContactDoug Farrell, VP, Investor Relationsir@quantum-si.com

    Media ContactKatherine Atkinson, SVP of Commercial Marketingmedia@quantum-si.com

    Source:Quantum-Si Incorporated

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com